Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
American Journal of Ophthalmology|March 18, 2019
Three-Year Follow-Up of Phase 1 and 2a rAAV.sFLT-1 Subretinal Gene Therapy Trials for Exudative Age-Related Macular DegenerationElizabeth P Rakoczy, Aaron L Magno, Chooi-May Lai, et al.
Experimental Eye Research|April 8, 2014
Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathyJoanna Wisniewska-Kruk, Ingeborg Klaassen, Ilse M C Vogels, et al.
American Journal of Ophthalmology|March 2, 2017
Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation TrialIan J Constable, Chooi-May Lai, Aaron L Magno, et al.
Investigative Ophthalmology & Visual Science|April 10, 2009
rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vectorChooi-May Lai, Marie J Estcourt, Matthew Wikstrom, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2024
Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retinaSatheesh Kumar, Yi-Wen Hsiao, Vickie H Y Wong, et al.
Lancet (London, England)|October 4, 2015
Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trialElizabeth P Rakoczy, Chooi-May Lai, Aaron L Magno, et al.
The British Journal of Ophthalmology|June 21, 2005
Generation of transgenic mice with mild and severe retinal neovascularisationC-M Lai, S A Dunlop, L A May, et al.
Ebiomedicine|November 21, 2016
Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular DegenerationIan J Constable, Cora M Pierce, Chooi-May Lai, et al.
Plos One|June 7, 2013
Pericytes derived from adipose-derived stem cells protect against retinal vasculopathyThomas A Mendel, Erin B D Clabough, David S Kao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2005
Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeysChooi-May Lai, Wei-Yong Shen, Meliha Brankov, et al.
Pageof 5